SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-15-003463
Filing Date
2015-02-26
Accepted
2015-02-26 10:12:18
Documents
4
Period of Report
2015-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20150226_8k.htm 8-K 27694
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 23298
3 headerb.jpg GRAPHIC 7598
4 headera.jpg GRAPHIC 9113
  Complete submission text file 0001437749-15-003463.txt   75721
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 15650695
SIC: 2836 Biological Products, (No Diagnostic Substances)